Hi, what are you looking for?
Lexeo Therapeutics filed for an IPO on Friday. The company develops genetic medicines, with candidates for treatment of Friedreich’s ataxia and Alzheimer’s currently being evaluated. Lexeo did not disclose the number of shares it plans to offer nor did it provide a price range.
Read the full article here
This article was written by Follow Beyond Saving is a professional in commercial real estate providing research on REITs with a focus on properties...
This article was written by Follow I’m Jason Ditz and I have 20 years of experience in foreign policy research. My work has appeared...
